Northeast Health Wangaratta (NHW) has expanded its maternity services with the introduction of a new labour pain relief option, further strengthening choice and access for women across the North East.
From 6 February 2026, remifentanil patient controlled intravenous analgesia (PCIA) has been available for women during labour. The medication is administered through a drip connected to an electronic pump, allowing women to self-administer small doses during contractions. It works quickly, with effects usually felt within 20 to 30 seconds, and wears off rapidly. Women are closely monitored by trained midwifery and medical staff throughout its use.
While remifentanil does not remove all pain, many women find it helpful. It may be suitable for women who cannot have an epidural or prefer an alternative option.
The introduction comes at a time of strong growth in NHW’s maternity program. The service welcomed 770 babies in 2025, reflecting increasing demand and community confidence in local maternity care.
NHW continues to offer a comprehensive range of birthing options, including antenatal care with midwives and obstetric doctors, shared care arrangements with GPs, and Midwifery Group Practice for women seeking continuity of care. The health service has reaffirmed its commitment to maintaining safe, exceptional birthing services locally, ensuring families can access care close to home.
NHW Chief Executive Officer Libby Fifis said, “Demand for maternity services across our catchment continues to grow, and with that growth comes a responsibility to ensure women have access to safe, contemporary and evidence-based care close to home,” Ms Fifis said.
“The introduction of remifentanil PCIA gives women another option when planning their birth experience. Every labour is different, and having a broader range of pain relief choices supports more personalised and respectful care.”
The new service followed extensive staff training and clinical governance processes to ensure safe implementation. NHW is also undertaking a prospective study examining remifentanil use in a regional hospital setting, contributing valuable insights to maternity care across regional Victoria.
Women planning to give birth at NHW are encouraged to speak with their midwife or doctor about the full range of birthing and pain relief options available.